(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -3.10%-1.53M | -18.03%-919.86K | -26.46%-637.61K | 37.48%-5.54M | 17.19%-2.77M | -11.45%-1.48M | 64.11%-779.36K | 74.90%-504.18K | -22.67%-8.86M | -162.60%-3.34M |
Net income from continuing operations | -30.53%-2.27M | 15.59%-2.16M | 13.53%-1.84M | 22.95%-9.37M | 28.17%-2.95M | -23.65%-1.74M | 38.28%-2.56M | 15.12%-2.12M | 1.86%-12.16M | 32.48%-4.11M |
Operating gains losses | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 13.88%351.03K | 14.64%343.9K | 2.14%347.76K | -53.15%526.69K | -259.06%-422K | -48.77%308.24K | 143.70%299.98K | 153.94%340.46K | 586.18%1.12M | 330.27%265.31K |
Asset impairment expenditure | ---69.68K | --288.09K | ---74.92K | 774.41%344.16K | 13,220.78%344.16K | --0 | --0 | --0 | --39.36K | ---2.62K |
Remuneration paid in stock | 109.26%169.3K | -114.28%-27.61K | 15.33%254.4K | -69.75%601K | -74.73%106.13K | 113.21%80.9K | -88.98%193.38K | -48.05%220.59K | -31.56%1.99M | -83.37%420.04K |
Other non cashItems | 231.82%67.88K | 215.61%140.16K | 3,384.51%177.3K | 1,864.63%1.06M | 2,215.20%1.01M | 2,935.01%20.46K | 6,234.95%44.41K | -157.44%-5.4K | -97.91%54.18K | -97.15%43.41K |
Change In working capital | 239.15%218.3K | -62.41%467.18K | -53.58%493.59K | 1,209.00%1.3M | -2,501.61%-853.44K | -481.28%-156.87K | 1,175.15%1.24M | 1,514.68%1.06M | 124.11%98.98K | -88.07%35.54K |
-Change in receivables | 212.16%493.22K | -191.58%-641.49K | -154.53%-69.46K | 162.66%56.81K | 592.21%589.17K | -381.56%-439.75K | -83.70%-220K | 1,826.00%127.4K | 8.53%-90.66K | -160.49%-119.7K |
-Change in inventory | 210.11%463.53K | 161.80%330K | 6,910.77%170.75K | -128.63%-1.2M | 26.91%-242.7K | -118.23%-420.97K | ---534.02K | ---2.51K | ---524.95K | ---332.05K |
-Change in payables and accrued expense | -116.88%-88.45K | -97.86%42.69K | -170.09%-657.69K | 216.13%2.26M | -346.24%-1.2M | 572.77%523.85K | 819.24%2M | 1,484.48%938.35K | 329.48%714.59K | 386.89%487.28K |
-Change in other working capital | ---650K | --735.97K | --1.05M | --180K | --0 | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -3.10%-1.53M | -18.03%-919.86K | -26.46%-637.61K | 37.48%-5.54M | 17.19%-2.77M | -11.45%-1.48M | 64.11%-779.36K | 74.90%-504.18K | -22.89%-8.86M | -165.30%-3.34M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 455.97%710.98K | 60.95%-122.43K | 185.28%27.29K | 76.11%-221.1K | 94.60%-3.42K | 119.21%127.88K | -292.59%-313.55K | 72.58%-32K | -61.85%-925.48K | 88.44%-63.34K |
Net PPE purchase and sale | 43.07%-15.97K | -54.91%-122.43K | 195.16%27.29K | 85.73%-109.86K | 137.28%25.91K | 95.63%-28.06K | -77.87%-79.03K | -101.00%-28.68K | -716.01%-769.78K | 26.33%-69.5K |
Net intangibles purchas and sale | -109.03%-14.09K | ---- | ---- | 28.56%-111.23K | -576.49%-29.33K | 749.91%155.94K | ---- | ---- | 16.77%-155.7K | 103.77%6.16K |
Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---3.32K | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 455.97%710.98K | 60.95%-122.43K | 185.28%27.29K | 76.11%-221.1K | 94.60%-3.42K | 119.21%127.88K | -292.59%-313.55K | 72.58%-32K | -61.85%-925.48K | 88.44%-63.34K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0.92%1.09M | -47.23%686.42K | 8,161.06%996.27K | -45.50%5.07M | -16.95%2.7M | 4,849.95%1.08M | 7,350.19%1.3M | -100.20%-12.36K | 0.36%9.3M | 1,168.28%3.26M |
Net issuance payments of debt | 3,938.46%2.47M | 210.37%97.63K | -2,610.86%-500.37K | 960.19%1.19M | 2,103.15%1.36M | -183.55%-64.27K | -314.52%-88.46K | 29.78%-18.46K | 77.91%-138.17K | -1,698.30%-67.88K |
Net common stock issuance | -101.27%-14.5K | -63.91%501.43K | 24,439.06%1.5M | -61.03%3.66M | -66.32%1.12M | 114,099,200.00%1.14M | 3,480.65%1.39M | -99.90%6.1K | -7.94%9.38M | 656.10%3.32M |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | 283.95%224.92K | --224.92K | --0 | ---- | ---- | 194.59%58.58K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 0.92%1.09M | -47.23%686.42K | 8,161.06%996.27K | -45.50%5.07M | -16.95%2.7M | 4,849.95%1.08M | 7,350.19%1.3M | -100.20%-12.36K | 0.36%9.3M | 1,168.28%3.26M |
Net cash flow | ||||||||||
Beginning cash position | -34.02%175.47K | 269.37%397.32K | -99.86%963 | -49.50%677.47K | -96.41%13.62K | -90.30%265.95K | -97.91%107.57K | -49.50%677.47K | 2,251.70%1.34M | -89.25%379.27K |
Current changes in cash | 196.01%267.94K | -271.18%-355.87K | 170.36%385.95K | -43.52%-688.57K | 54.56%-68.85K | 86.18%-279.07K | 109.31%207.89K | -113.97%-548.54K | -132.21%-479.78K | 92.83%-151.51K |
Effect of exchange rate changes | -297.77%-52.89K | 370.70%134.02K | 148.71%10.41K | 106.54%12.06K | -87.50%56.19K | 107.83%26.74K | 69.14%-49.51K | 83.80%-21.37K | 10.11%-184.32K | 715.92%449.71K |
End cash Position | 2,766.80%390.52K | -34.02%175.47K | 269.37%397.32K | -99.86%963 | -99.86%963 | -96.41%13.62K | -90.30%265.95K | -97.91%107.57K | -49.50%677.47K | -49.50%677.47K |
Free cash from | -15.04%-1.56M | 7.59%-1.01M | -20.02%-639.55K | 41.13%-5.76M | 18.63%-2.77M | 32.10%-1.36M | 51.31%-1.1M | 74.93%-532.86K | -30.63%-9.78M | -124.48%-3.41M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data